Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,685,232
+$217,393 QoQ
Shares Held
6,697
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#2,102
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First PREMIER Bank holds $19,058,988 across 11 Drug Manufacturers - General names. ABBV ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,024 | $9,149,013 | |
| 2 | AMGN |
Amgen Inc
|
8,903 | $3,223,954 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,539 | $2,767,761 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
6,697 | $1,685,232 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,692 | $719,126 | |
| 6 | LLY |
ELI LILLY & Co
|
538 | $645,292 | |
| 7 | PFE |
Pfizer Inc
|
15,632 | $376,417 | |
| 8 | GSK |
GSK plc
|
4,433 | $232,377 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,685,232 | 6,697 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,467,839 | 6,749 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,546,648 | 6,769 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,540,898 | 6,655 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,239,941 | 6,680 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,461,611 | 6,976 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,248,520 | 7,026 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,466,486 | 7,426 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $1,238,373 | 7,220 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,314,761 | 7,220 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,109,584 | 7,160 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,104,534 | 7,410 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,076,491 | 7,990 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,601,188 | 10,047 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $1,586,361 | 9,816 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $1,261,034 | 9,396 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,445,216 | 9,436 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $1,549,931 | 9,561 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,256,917 | 9,283 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,000,386 | 9,274 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,031,668 | 9,159 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $960,343 | 8,874 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $881,200 | 8,224 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $573,538 | 6,548 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $642,882 | 6,548 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $502,700 | 6,598 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||